Star Lake Technology Sells Financial Assets Feed Additives Market Slump

On June 19, Star Lake Technology (600866, stock bar) announced that from June 10 to June 18, it sold some of the company's available-for-sale financial assets (stocks) through the stock exchange's stock trading system, with a loss of 5.8 million yuan on net profit in the first half of this yearHWt
The announcement shows that, after preliminary estimates, after deducting stock costs and related taxes and fees, Star Lake Technology's sale of available-for-sale financial assets (stocks) on its semi-annual report net profit for this year's amount of about -5.8 million yuan, the absolute value of the most recent fiscal year audited net profit of 28.70%At the close of trading today, Star Lake Technology was down 4.15% at 4.85 yuanHWt
It is understood that Star Lake Technology lost 40.72 million in the first three quarters of last yearAt the end of last year, it received a government subsidy of 40 million yuan and relied on the sale of some of its available-for-sale financial assets, including 1.81 million shares sold by Guangfa Securities (000776, bar bar), for a total profit of nearly 33.91 millionAfter that, the company turned a lossIn the first quarter of this year, Star Lake Technology reported revenue of 187 million yuan, a decrease of 19.85 percent year-on-year, and a net profit loss attributable to shareholders of listed companies was 57.36 million yuanSome professionals believe that Star Lake Technology is once again selling available for sale of financial assets or subject to operational pressuresIn recent years, affected by overcapacity and irrational competition in prices in the industry, the market price of flavornucleotide dsodium in the leading products of Xinghu Technology has continued to decline sharply, and the price of feed additive products has been low, seriously affecting the profitability of its main businessHWt
At present, Star Lake science and technology feed additives and food additives business losses, biochemical drugs business performed well Last year, Star Lake Technology biochemical drug sales revenue of 343 million yuan, an increase of 3.93 percent year-on-year In terms of gross margin, the gross margin of biochemical sinfys decreased significantly, but remained at around 25% Star Lake Technology is gradually divesting other assets, focusing on the main biopharmaceutical industry HWt
HWt news on June 19, Star Lake Technology (600866, stock bar) announced that from June 10 to June 18, its stock exchange trading system through the sale of some of the company's available-for-sale financial assets (stocks), the impact on the first half of this year's net profit of 5.8 million yuan HWt
　　The announcement shows that, after preliminary estimates, after deducting stock costs and related taxes and fees, Star Lake Technology's sale of available-for-sale financial assets (stocks) on its semi-annual report net profit for this year's amount of about -5.8 million yuan, the absolute value of the most recent fiscal year audited net profit of 28.70% At the close of trading today, Star Lake Technology was down 4.15% at 4.85 yuan HWt
　　It is understood that Star Lake Technology lost 40.72 million in the first three quarters of last year At the end of last year, it received a government subsidy of 40 million yuan and relied on the sale of some of its available-for-sale financial assets, including 1.81 million shares sold by Guangfa Securities (000776, bar bar), for a total profit of nearly 33.91 million After that, the company turned a loss In the first quarter of this year, Star Lake Technology reported revenue of 187 million yuan, a decrease of 19.85 percent year-on-year, and a net profit loss attributable to shareholders of listed companies was 57.36 million yuan Some professionals believe that Star Lake Technology is once again selling available for sale of financial assets or subject to operational pressures In recent years, affected by overcapacity and irrational competition in prices in the industry, the market price of flavornucleotide dsodium in the leading products of Xinghu Technology has continued to decline sharply, and the price of feed additive products has been low, seriously affecting the profitability of its main business HWt
　　At present, Star Lake science and technology feed additives and food additives business losses, biochemical drugs business performed well Last year, Star Lake Technology biochemical drug sales revenue of 343 million yuan, an increase of 3.93 percent year-on-year In terms of gross margin, the gross margin of biochemical sinfys decreased significantly, but remained at around 25% Star Lake Technology is gradually divesting other assets, focusing on the main biopharmaceutical industry HWt
HWt and "Star Lake Technology, Feed Additives," Related Article: Recommended Topics: News Click: Top Pictures News: News ReviewS: Seven Mouths Forum: